OUR PRODUCTS

MOBILE APPS

GENERAL INFO

IMNN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Imunon (IMNN) Earnings Date & Reports

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body’s natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

IMNN is expected to report earnings to fall 90.23% to -20 cents per share on November 17

Q3'25

Est.

$-0.21

Q2'25

Missed

by $1.83

Q1'25

Beat

by $0.08

Q4'24

Beat

by $0.11

Q3'24

Beat

by $0.05

The last earnings report on August 05 showed earnings per share of -215 cents, missing the estimate of -31 cents. With 80.20K shares outstanding, the current market capitalization sits at 15.16M.

View a ticker or compare two or three

Compare

IMNN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IMNN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMNN showed earnings on August 05, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a company which engages in the provision of oncology drug development services

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Medical Specialties

Address

997 Lenox Drive

Phone

+1 609 896-9100

Employees

Web

https://www.imunon.com